Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08890_nanopub.RA9uIV_gFwpo_tUgfR-C1aXL-VIEwBfDIqZFVnz91fD9g#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB08890 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08890 label "Linaclotide [drugbank:DB08890]" assertion.
- drugbank:DB08890 seeAlso DB08890 assertion.
- drugbank:DB08890 seeAlso linaclotide.html assertion.
- drugbank:DB08890 seeAlso linzess-drug.htm assertion.
- drugbank:DB08890 identifier "drugbank:DB08890" assertion.
- drugbank:DB08890 description "Linaclotide is an orally administered, peptide agonist of guanylate cyclase 2C for the treatment of irritable bowel syndrome. Chemically, it is a heterodetic cyclic peptide and consists of fourteen amino acids. The protein sequence is as follows: Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr. There are three disulfide bonds which are located between Cys1 and Cys6; between Cys2 and Cys10; and between Cys5 and Cys13. FDA approved on August 30, 2012." assertion.
- drugbank:DB08890 title "Linaclotide" assertion.
- drugbank:DB08890 bio2rdf_vocabulary:identifier "DB08890" assertion.
- drugbank:DB08890 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08890 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08890" assertion.
- drugbank:DB08890 bio2rdf_vocabulary:x-identifiers.org DB08890 assertion.
- drugbank:DB08890 drugbank_vocabulary:drugbank-id "DB08890" assertion.
- drugbank:DB08890 drugbank_vocabulary:x-cas cas:851199-59-2 assertion.
- drugbank:DB08890 drugbank_vocabulary:x-ahfs ahfs:56:92 assertion.
- drugbank:DB08890 drugbank_vocabulary:x-atc atc:A06AX04 assertion.
- drugbank:DB08890 drugbank_vocabulary:x-chebi chebi:68551 assertion.
- drugbank:DB08890 drugbank_vocabulary:x-kegg kegg:D09355 assertion.
- drugbank:DB08890 drugbank_vocabulary:x-wikipedia wikipedia:Linaclotide assertion.
- drugbank:DB08890 drugbank_vocabulary:x-ndc ndc:0456-1202-30 assertion.